A Systematic Review and Meta-Analysis of Trifluridine/Tipiracil plus Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Evidence from Real-World Series.

Published in: Current oncology (Toronto, Ont.) (2023)

The current systematic review and meta-analysis reports the efficacy of trifluridine/tipiracil with bevacizumab in advanced lines of therapy for metastatic colorectal cancer in the setting of clinical practice outside clinical trials. Discovery of predictive biomarkers of response to trifluridine/tipiracil with bevacizumab will promote the tailoring of this treatment to individual patients to maximize clinical benefit.

Keyphrases

metastatic colorectal cancer
clinical trial
clinical practice
end stage renal disease
newly diagnosed
small molecule
peritoneal dialysis
emergency department
single cell
adverse drug
patient reported